Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
G Stock Forecast 2025-2026
$42.10
Current Price
$7.55B
Market Cap
Buy 5
Hold 6
Sell 0
Wall St Analyst Ratings
Distance to G Price Targets
+33.0%
To High Target of $56.00
+18.8%
To Median Target of $50.00
+14.0%
To Low Target of $48.00
G Price Momentum
-3.4%
1 Week Change
-4.5%
1 Month Change
+35.6%
1 Year Change
-2.0%
Year-to-Date Change
-25.8%
From 52W High of $56.76
+38.6%
From 52W Low of $30.38
📊 TOP ANALYST CALLS
Did G Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Genpact is one of their latest high-conviction picks.
Latest G Stock Price Targets & Analyst Predictions
Based on our analysis of 13 Wall Street analysts, G has a neutral consensus with a median price target of $50.00 (ranging from $48.00 to $56.00). The overall analyst rating is Buy (7.6/10). Currently trading at $42.10, the median forecast implies a 18.8% upside. This outlook is supported by 5 Buy, 6 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Mayank Tandon at Needham, projecting a 33.0% upside. Conversely, the most conservative target is provided by David Koning at Baird, suggesting a 14.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
G Analyst Ratings
5
Buy
6
Hold
0
Sell
G Price Target Range
Low
$48.00
Average
$50.00
High
$56.00
Current: $42.10
Latest G Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for G.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 8, 2025 | Baird | David Koning | Neutral | Maintains | $50.00 |
| May 8, 2025 | Needham | Mayank Tandon | Buy | Maintains | $50.00 |
| Feb 10, 2025 | Mizuho | Dan Dolev | Neutral | Maintains | $55.00 |
| Feb 7, 2025 | Needham | Mayank Tandon | Buy | Maintains | $65.00 |
| Jan 21, 2025 | Jefferies | Surinder Thind | Buy | Upgrade | $55.00 |
| Nov 11, 2024 | Needham | Mayank Tandon | Buy | Maintains | $55.00 |
| Nov 8, 2024 | Baird | David Koning | Neutral | Maintains | $48.00 |
| Nov 8, 2024 | TD Cowen | Bryan Bergin | Hold | Maintains | $45.00 |
| Oct 9, 2024 | Baird | David Koning | Neutral | Maintains | $44.00 |
| Sep 9, 2024 | Jefferies | Surinder Thind | Hold | Maintains | $40.00 |
| Sep 6, 2024 | JP Morgan | Tien-Tsin Huang | Neutral | Maintains | $43.00 |
| Aug 12, 2024 | BMO Capital | Keith Bachman | Market Perform | Maintains | $42.00 |
| Aug 9, 2024 | TD Cowen | Bryan Bergin | Hold | Maintains | $36.00 |
| Aug 9, 2024 | Needham | Mayank Tandon | Buy | Maintains | $42.00 |
| Jul 17, 2024 | JP Morgan | Tien-Tsin Huang | Neutral | Upgrade | $40.00 |
| May 10, 2024 | Wedbush | Moshe Katri | Neutral | Reiterates | $35.00 |
| May 10, 2024 | BMO Capital | Keith Bachman | Market Perform | Maintains | $38.00 |
| May 10, 2024 | Needham | Mayank Tandon | Buy | Reiterates | $40.00 |
| Apr 22, 2024 | Citigroup | Ashwin Shirvaikar | Neutral | Maintains | $33.00 |
| Feb 9, 2024 | JP Morgan | Tien-Tsin Huang | Underweight | Maintains | $43.00 |
Genpact Ltd. (G) Competitors
The following stocks are similar to Genpact based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Genpact Ltd. (G) Financial Data
Genpact Ltd. has a market capitalization of $7.55B with a P/E ratio of 14.7x. The company generates $4.85B in trailing twelve-month revenue with a 10.9% profit margin.
Revenue growth is +7.4% quarter-over-quarter, while maintaining an operating margin of +15.1% and return on equity of +22.2%.
Valuation Metrics
Market Cap
$7.55B
Enterprise Value
$8.43B
P/E Ratio
14.7x
PEG Ratio
12.5x
Price/Sales
1.6x
Growth & Margins
Revenue Growth (YoY)
+7.4%
Gross Margin
+35.3%
Operating Margin
+15.1%
Net Margin
+10.9%
EPS Growth
+11.9%
Financial Health
Cash/Price Ratio
+7.7%
Current Ratio
2.5x
Debt/Equity
58.9x
ROE
+22.2%
ROA
+9.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Genpact Ltd. (G) Business Model
About Genpact Ltd.
What They Do
Provides digital transformation and business process management.
Business Model
Genpact generates revenue by offering professional services that include digital transformation and business process management solutions. The company serves a variety of industries, leveraging advanced analytics, artificial intelligence, and automation to enhance operational efficiency and agility for its clients.
Additional Information
Founded as a unit within General Electric and spun off in 2005, Genpact has established itself as a leader in the global outsourcing market. With headquarters in New York City and operations in over 25 countries, the company is well-positioned for scalability and supports organizations in navigating complex market demands and regulatory landscapes.
Company Information
Sector
Technology
Industry
Information Technology Services
Employees
140,000
CEO
Mr. Balkrishan Kalra
Country
Bermuda
IPO Year
2007
Website
www.genpact.comGenpact Ltd. (G) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Unisys Stock is at a 4.92X P/E: Should You Buy, Sell or Retain?
UIS trades at just 4.92X forward P/E, with major wins in device services and AI fueling its turnaround potential.
Jun 16, 2025
By Harendra Ray
Analyst Blog
Latest News
Quick Summary
Genpact (NYSE: G) launched Genpact RapidReplace, an AI-driven solution that reduces property claims processing time from weeks to days, enhancing customer experience through streamlined fulfillment.
Why It Matters
Genpact's AI solution significantly reduces claims settlement time, improving efficiency and customer satisfaction, which can enhance revenue and profitability, making it attractive for investors.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
A report by Genpact and AWS reveals that 69% of insurance firms have adopted AI, yet only 36% of US customers report improved digital experiences, highlighting growth and governance challenges.
Why It Matters
The report highlights a gap between AI adoption and customer experience in insurance, indicating potential growth opportunities or risks for companies lagging in AI fluency and governance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Genpact has acquired XponentL Data to enhance its advanced technology solutions, boosting its data and AI capabilities and domain expertise.
Why It Matters
Genpact's acquisition of XponentL enhances its AI and data capabilities, positioning the company for growth and competitive advantage in advanced technology solutions, likely boosting investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Genpact Limited (NYSE: G) declared a cash dividend of $0.17 per share for Q2 2025, payable on June 30 to shareholders on record by June 18.
Why It Matters
Genpact's cash dividend signals financial health and shareholder returns, potentially attracting income-focused investors and positively impacting stock demand.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Genpact (G) recently reported earnings, and investors may want to monitor upcoming developments that could impact the stock's performance.
Why It Matters
Upcoming developments or trends following Genpact's recent earnings could impact stock performance, influencing investor sentiment and trading decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Genpact is rated a strong Buy, benefiting from a focus on Data-Tech-AI, strong Q1 FY25 results (8.3% revenue growth), and initiatives like the AI Gigafactory, indicating a potential 30% upside.
Why It Matters
Genpact's shift to Data-Tech-AI, strong Q1 growth, and operational efficiency position it for significant upside, enhancing its attractiveness as a long-term investment.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About G Stock
What is Genpact Ltd.'s (G) stock forecast for 2025?
Based on our analysis of 13 Wall Street analysts, Genpact Ltd. (G) has a median price target of $50.00. The highest price target is $56.00 and the lowest is $48.00.
Is G stock a good investment in 2025?
According to current analyst ratings, G has 5 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $42.10. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for G stock?
Wall Street analysts predict G stock could reach $50.00 in the next 12 months. This represents a 18.8% increase from the current price of $42.10. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Genpact Ltd.'s business model?
Genpact generates revenue by offering professional services that include digital transformation and business process management solutions. The company serves a variety of industries, leveraging advanced analytics, artificial intelligence, and automation to enhance operational efficiency and agility for its clients.
What is the highest forecasted price for G Genpact Ltd.?
The highest price target for G is $56.00 from Mayank Tandon at Needham, which represents a 33.0% increase from the current price of $42.10.
What is the lowest forecasted price for G Genpact Ltd.?
The lowest price target for G is $48.00 from David Koning at Baird, which represents a 14.0% increase from the current price of $42.10.
What is the overall G consensus from analysts for Genpact Ltd.?
The overall analyst consensus for G is neutral. Out of 13 Wall Street analysts, 5 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $50.00.
How accurate are G stock price projections?
Stock price projections, including those for Genpact Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 19, 2025 3:57 AM UTC